We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YUMC:NYSEYum China Holdings, Inc. Analysis

Data as of 2026-09-21 - not real-time

$41.12

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Yum China Holdings, Inc. trades at $41.12, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. The last 30 days have lost 14.7%. RSI sits at 27.8, which reads as oversold, and MACD momentum is bearish. Watch $41.04 as support and $49.73 as the nearer resistance level.
Multiples put this in undervalued territory at a P/E of 15.1. The average analyst target implies 50.6% above today's level. Revenue is growing at 12.6% on a 7.8% profit margin. The 2.82% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 23.9%, a beta of 0.31 and a maximum drawdown of 30.7%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.

Top Market Events

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions...The end of the earnings season is always a good time to take a step back and see who shined and who didn’t .Yum China stock is supported by a new share repurchase disclosed on September 18, 2026, alongside so

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 27.8 signals oversold conditions
  • Trading below the 200-day average of 47.57

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 27.8 signals oversold conditions
  • Trading below the 200-day average of 47.57

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +50.6% versus the current price
  • Revenue growth of +12.6%
  • P/E ratio of 15.1

Key Metrics & Analysis

Financial Health

Revenue Growth12.60%
Profit Margin7.84%
P/E Ratio15.1
ROE16.81%
ROA8.08%
Debt/Equity37.98
P/B Ratio2.7
Op. Cash Flow$1.6B
Free Cash Flow$859.9M

Technical Analysis

TrendBearish
RSI27.8
Support$41.04
Resistance$49.73
MA 20$44.23
MA 50$45.24
MA 200$47.57
MACDBearish
VolumeDecreasing
Fear & Greed Index94.7

Valuation

Fair Value$50.36
Target Price$61.92
Upside/Downside50.57%
GradeUndervalued
TypeBlend
Dividend Yield2.82%

Risk Assessment

Beta0.31
Volatility23.89%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.